Video

Boehringer Ingelheim BioXcellence™ Capacity Update October 2024: Large Molecule Drug Substance

Source: Boehringer Ingelheim Biopharmaceuticals GmbH

This content was created by Boehringer Ingelheim BioXcellence™

Explore Boehringer Ingelheim BioXcellence™ in this comprehensive session, which showcases our end-to-end contract manufacturing services for mammalian cell culture and microbial technologies.

Delve into our global production network, highlighting the unique strengths of each site, and gain insights into our broad suite of offerings, including clinical and commercial supply, aseptic filling, and in-house analytics.

With a track record of bringing 47 biopharmaceuticals to market in partnership, Boehringer Ingelheim BioXcellence™ is poised to support your biologic’s journey to commercial success!

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests: